Plaintiff
Defendant
- Parties: The plaintiffs were Amgen Canada Inc and Onyx Therapeutics Inc. The defendant was Natco Pharma (Canada) Inc.
- Subject Matter: This was an action under the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Dec. 15, 2023.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-2323-23Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
03 November 2023Download documents